Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dong-A, Genentech.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Eli Lilly, Keybioscience, Turnstone.

Biopharmas raising money in public or private financings, including: Hemostemix, Immatics.

A quick look back at top stories.

New hires and promotions in the biopharma industry, including: Innate.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allakos, Cantargia, Capricor.

The top 10 biopharma stock gainers and losers for the week.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2024.

Year-to-date money raised in public, private and other financings of biopharma companies.

Coming off September, which saw five biopharma IPOs raise more than $1 billion, two firms priced upsized offerings that could total more than $330 million.